SCHEMBL19258863

SCHEMBL19258863

N#Cc1c(C(F)(F)F)ccc(-c2ccccn2)c1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SQOR Q9Y6N5 3/20 0.41
GRM5 P41594 2/20 0.39
KDM4E B2RXH2 7/20 0.39
ALDH1A1 P00352 5/20 0.39
GAA P10253 4/20 0.39
HPGD P15428 4/20 0.39
MEN1 O00255 2/20 0.39
MAPT P10636 2/20 0.39
TSHR P16473 2/20 0.39
KMT2A Q03164 2/20 0.39
ALOX12 P18054 1/20 0.39
RECQL P46063 1/20 0.39
HBB P68871 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HSD17B10 Q99714 1/20 0.39
GLA P06280 2/20 0.36
POLB P06746 2/20 0.36
HCRTR1 O43613 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3048746 0.82 SQOR (0.44) SQORGRM5KDM4EALDH1A1GAA
SCHEMBL30150883 0.82 SQOR (0.44) SQORGRM5KDM4EALDH1A1GAA
SCHEMBL17866547 0.75 SQOR (0.43) SQORGRM5KDM4EALDH1A1GAA
SCHEMBL23629598 0.72 KDM4E (0.46) SQORGRM5KDM4EALDH1A1GAA
SCHEMBL12679741 0.71 KDM4E (0.50) SQORGRM5KDM4EALDH1A1GAA
SCHEMBL31211635 0.71 TGFBR1 (0.56) GRM5KDM4EALDH1A1HPGDTSHR
SCHEMBL4166620 0.71 TGFBR1 (0.56) GRM5KDM4EALDH1A1HPGDTSHR
SCHEMBL30090604 0.71 TGFBR1 (0.56) GRM5KDM4EALDH1A1HPGDTSHR
SCHEMBL3445756 0.71 KDM4E (0.42) KDM4EALDH1A1GAAHPGDMAPT
SCHEMBL16681034 0.71 SQOR (0.45) SQORGRM5KDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170237021-A1 ORGANIC IRIDIUM COMPLEX FOR ORGANIC ELECTROLUMINESCENT ELEMENTS TANAKA KIKINZOKU KOGYO K.K. (JP) 2017-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170237021-A1 ORGANIC IRIDIUM COMPLEX FOR ORGANIC ELECTROLUMINESCENT ELEMENTS L1CAM, ETFA, TTI2 SQOR 877/4885GRM5 3368/4885KDM4E 2850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.